Folate Market Size & Share, by, Type (5-MTHF Calcium Salt, 5-MTHF Glucosamine Salt); Source (Fruit, Milk, Green Vegetables, Liver, Seafood); Form (Tablet, Capsules, Powder, Lozenges, Gummies, Others); End-User - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 6213
  • Published Date: Jun 19, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Folate Market size was over USD 4.9 Billion in 2023 and is anticipated to reach USD 10.9 Billion by the end of 2036, growing at around 6.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of folate is estimated at USD 5.2 Billion.

 This market growth is set to be dominated by rising pregnancy among women. However, with increasing pregnancy, the risk of abnormal birth has also surged. According to the WHO, every year over 8 million newborns across the world are born with a birth defect. Moreover, in low- and middle-income countries nine out of every ten children are birthed with a major birth defect. Owing to this, the adoption of folate medications has grown significantly to limit the possibilities of abnormalities and miscarriage.


Folate Market
Get more information on this report: Request Free Sample PDF

Folate Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing prevalence of kidney disease - According to NCBI, over 10% of the population globally is affected by chronic kidney disease. This percentage further indicates about 800 million people.

    The major influencing factor in CKD patients poor maternal nutrition, notwithstanding improvements, remains significantly widespread in huge parts of the world. As a result, it increases the likelihood of gestational hypertension and diabetes. Hence, the demand for folate is also evaluated to rise since it helps reduce homocysteine levels.
  • Growing importance of folate among health-conscious people - The pandemic affected numerous facets of daily life. In 2020, nutrition for improving immunity became the top concern for people worldwide.

    For instance, around the world, nearly 59% of consumers believe the pandemic has rendered them more aware of the significance of living healthy lives in avoiding health problems. Moreover, while consumers were less worried about COVID-19 in April 2022 (about 43%) than in April 2020 (close to 75%), they remained enthusiastic about adopting fundamental nutritional changes. Therefore, the demand for folate is estimated to rise among the adult population due to busy lifestyles.
  • Rising geriatric population - According to the WHO, 1 in 6 people in 2030 across the globe is poised to be aged 60 years or over. Studies have indicated that seniors who consume the required daily dose of folic acid improve their mental agility and cognitive function. Moreover, folic acid improves digestion of proteins and amino acid metabolism.

Challenges

  • Growing price of folate - The folate market is expected to be hampered by increasing issues related to high doses and vitamin B12 deficiency. Furthermore, rising prices and a tight supply-demand chain may pose challenges in the upcoming years.
  • Lack of awareness among consumers - Consumers' ignorance of the benefits of fortified foods or folate supplements may impede market growth. Customers need to be educated on the positive effects of folate in reducing birth defects and improving overall health for the folate market to grow.
  • Growing competition from alternative products - The growth in the folate market products might be hindered by competition from additional nutrients or supplements that offer similar health benefits. Consumers who acquire fortified foods or alternative supplements may have an impact on the market for folate-specific products.

Folate Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

6.9%

Base Year Market Size (2023)

USD 4.9 billion

Forecast Year Market Size (2036)

USD 10.9 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Folate Segmentation

End-User (Food & Beverages, Pharmaceuticals & Nutraceuticals, Agriculture & Feed, Others)

Pharmaceuticals & nutraceuticals segment is expected to account for folate market share of around 50% by 2036. This growth of the segment is poised to be encouraged by the rising prevalence of cardiovascular disease. As per the World Health Organization, cardiovascular diseases (CVDs) are the major reason of death worldwide, taking about 17.9 million lives every year. 

One of the main factors for this growing prevalence is the surging consumption of unhealthy food. Hence, the utilization of folate is growing in the pharmaceutical sector. Furthermore, one of the research projects in 2020 has indicated that the consumption of folate reduces the risk of heart attack by about 15%, whereas reduces the possibility of stroke by 23%.

Type (5-MTHF Calcium Salt and 5-MTHF Glucosamine Salt)

The 5-MTHF calcium salt segment is projected to observe a notable rise in its revenue over the forecast period. This growth of the segment can be encouraged by the surging number of people suffering from anemia. For instance, in 2021, close to 2 billion population across the globe had anemia. This also indicates a rise of about 419 million cases over three decades. Anemia is usually caused due to the lack of red blood cells in the body which could be treated by 5-MTHF calcium salt.

However, the 5-MTHF glucosamine salt segment is also expected to observe growth in the market by 2036. This could be owing to rising government initiatives to provide the best medications to women during their pregnancy. Furthermore, this is also utilized significantly to treat infertility and hyperhomocysteinemia.

Our in-depth analysis of the folate market includes the following segments:

 

          Type

  • 5-MTHF Calcium Salt
  • 5-MTHF Glucosamine Salt

 

 

          Source

  • Fruit
  • Milk
  • Green Vegetables
  • Liver
  • Seafood

 

 

          Form

  • Tablet
  • Capsules
  • Powder
  • Lozenges
  • Gummies
  • Others

 

 

          End-User

  • Food & Beverages
  • Pharmaceuticals & Nutraceuticals
  • Agriculture & Feed
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Folate Industry - Regional Synopsis

North American Market Statistics

North America in folate market is expected to dominate revenue share of around 35% by the end of 2036. The major factor influencing the market growth in this region is the growing consumption of alcohol. Following the 2022 National Survey on Drug Use and Health (NSDUH), 221.3 million individuals aged 12 and up (78.5% of this age group) claimed to have drunk alcohol at some point in their lives. Hence, this has increased the risk of cardiovascular disease further necessitating the adoption of folate. 

Additionally, the US folate market is predicted to observe the highest growth over the forecast period due to the surging disposable income of the people in this area.

Furthermore, the Canadian market is poised to experience growth in the market over the coming years owing to growing investment in the pharmaceutical sector.

APAC Market Analysis

Folate market size for Asia Pacific region is projected to reach USD 3 Billion by 2036. This market growth in this region is expected to be dominated by a rising population. As projected by UNFPA, it is foreseen that around 60% of the population of the world resides in the Asia Pacific region. Further, this estimates around 4.3 billion individuals. With this, the production of natural folate is poised to rise. Also, the utilization of folate acid is growing in food & beverages to fill the folate deficiency gap.

Additionally, the China folate market is to rise in this region gathering the highest revenue compared to other nations. This could be on account of the surging use of folate as feed.

Moreover, with the growing possibilities of dementia, the market in India for folate is evaluated to experience growth. However, with the growing research & development activities the demand may rise in the country.

Additionally, the Japanese market is poised to rise due to the rising supply of folate, and the improving Japan's medical sector.

Research Nester
Folate
Get more information on this report: Request Free Sample PDF

Companies Dominating the Folate Landscape

    The folate market is predicted to be greatly influenced by the initiatives of the key players. These key players are significantly investing in R&D activities and collaborating with a number of companies to make their development reach the world. Some of the major players include:

    • ITM Isotope Technologies Munich SE (ITM)
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ImmunoGen Inc.
    • Medicamen Biotech Ltd.
    • Koninklijke DSM N.V
    • Superior Supplement Manufacturing
    • Gnosis
    • Seidler Chemical Co, Inc.
    • Nutritional Supplement Manufacturers, Inc.
    • AIE Pharmaceuticals, Inc.
    • Gemini Pharmaceuticals

In the News

  • ITM Isotope Technologies Munich SE (ITM), disclosed that it has entered into a license agreement with Merck KGaA's life science business in Darmstadt, Germany, to secure a worldwide exclusive license for the clinical research and marketing of radiolabeled folate derivatives for therapeutic and diagnostic applications against folate-receptor-positive malignant tumors.
  • ImmunoGen Inc. garnered accelerated approval from the US Food and Drug Administration (FDA) for ELAHERE (mirvetuximab soravtansine-gynx), which is used to treat adult patients with folate receptor alpha (FRα)-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have undergone one to three prior systemic treatments.

Author Credits:  Parul Atri


  • Report ID: 6213
  • Published Date: Jun 19, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of folate was over USD 4.9 billion.

The market size for folate is expected to cross USD 10.9 billion by the end of 2036 expanding at a CAGR of 6.9% during the forecast period i.e., between 2024-2036.

The major players in the market are ITM Isotope Technologies Munich SE (ITM), ImmunoGen Inc., Medicamen Biotech Ltd., Koninklijke DSM N.V, and others.

The pharmaceuticals & nutraceuticals segment is anticipated to garner a share/size of 50% during 2024-2036.

The North America folate sector is poised to hold a 35% share by the end of 2036.
Folate Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample